Advertisement
Screener

NEVRO CORP. Proceeds from Stock Options Exercised

NEVRO CORP. Proceeds from Stock Options Exercised

NEVRO CORP. reported Proceeds from Stock Options Exercised of $5.23 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2016-11-07

  • NEVRO CORP. proceeds from stock options exercised for the quarter ending 2016-09-30 was $1.53M, a 164.25% increase year-over-year.
  • NEVRO CORP. proceeds from stock options exercised for the quarter ending 2016-06-30 was $3.07M, a 106.52% increase year-over-year.
  • NEVRO CORP. proceeds from stock options exercised for the quarter ending 2016-03-31 was $633.00K, a 701.27% increase year-over-year.
  • NEVRO CORP. proceeds from stock options exercised for the quarter ending 2015-12-31 was $2.24M, a 24822.22% increase year-over-year.
  • NEVRO CORP. proceeds from stock options exercised for fiscal 2015 was $4.39M, a 355.19% increase from fiscal 2014.
  • NEVRO CORP. proceeds from stock options exercised for fiscal 2014 was $964.00K, a 768.47% increase from fiscal 2013.
  • NEVRO CORP. proceeds from stock options exercised for fiscal 2013 was $111.00K, a 92.75% decline from fiscal 2012.
  • NEVRO CORP. proceeds from stock options exercised for fiscal 2012 was $1.53M.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 month
2016-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$4.60M
derived: sum of 2 quarters · filed 2016-11-07
$5.23M
10-Q · filed 2016-11-07
$7.48M
derived: sum of 4 quarters · filed 2016-11-07
2016-06-30$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$3.70M
10-Q · filed 2016-08-08
$5.95M
derived: sum of 3 quarters · filed 2016-08-08
$6.53M
derived: sum of 4 quarters · filed 2016-11-07
2016-03-31$633.00K
10-Q · filed 2016-05-09
$2.88M
derived: sum of 2 quarters · filed 2016-05-09
$3.46M
derived: sum of 3 quarters · filed 2016-11-07
$4.94M
derived: sum of 4 quarters · filed 2016-11-07
2015-12-31$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$2.82M
derived: sum of 2 quarters · filed 2016-11-07
$4.31M
derived: sum of 3 quarters · filed 2016-11-07
$4.39M
10-K · filed 2016-02-29
2015-09-30$579.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$2.07M
derived: sum of 2 quarters · filed 2016-11-07
$2.15M
10-Q · filed 2016-11-07
$2.15M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30$1.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$1.57M
10-Q · filed 2016-08-08
$1.57M
derived: sum of 3 quarters · filed 2016-08-08
$1.99M
derived: sum of 4 quarters · filed 2016-08-08
2015-03-31$79.00K
10-Q · filed 2016-05-09
$88.00K
derived: sum of 2 quarters · filed 2016-05-09
$506.00K
derived: sum of 3 quarters · filed 2016-05-09
2014-12-31$9.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$427.00K
derived: sum of 2 quarters · filed 2016-02-29
$964.00K
10-K · filed 2016-02-29
2014-09-30$418.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$955.00K
10-Q · filed 2015-11-09
2014-06-30$537.00K
10-Q · filed 2015-08-06
2013-12-31$111.00K
10-K · filed 2016-02-29
2012-12-31$1.53M
10-K · filed 2015-03-18